TY - JOUR
T1 - Levels of Free Fatty Acids (FFA) are associated with insulin resistance but do not explain the relationship between adiposity and insulin resistance in hispanic americans
T2 - The IRAS family study
AU - Miller, Melissa R.
AU - Pereira, Rocio I.
AU - Langefeld, Carl D.
AU - Lorenzo, Carlos
AU - Rotter, Jerome I.
AU - Chen, Yii Der Ida
AU - Bergman, Richard N.
AU - Wagenknecht, Lynne E.
AU - Norris, Jill M.
AU - Fingerlin, Tasha E.
PY - 2012/9
Y1 - 2012/9
N2 - Context and Objective: We investigated whether free fatty acids (FFA) mediate the association between adiposity and insulin resistance in the Hispanic-American families of the Insulin Resistance Atherosclerosis Family Study. Design: In 815 Hispanic individuals in the Insulin Resistance Atherosclerosis Family Study, we tested for association between the following: 1) levels of adiposity [body mass index (BMI), visceral and sc adipose tissue area (VAT and SAT)] and circulating levels of FFA; 2) levels of circulating FFA and insulin sensitivity (SI); and 3) levels of adiposity and S I, additionally testing to see whether levels of FFA mediated or modified the relationship between adiposity and SI. Results: After adjusting for age, sex, clinic site, and admixture, increasing levels of BMI, VAT, and SAT were weakly associated with increasing levels of circulating FFA (BMI: P = 0.024; VAT: P =2.33 × 10-3; SAT: P = 0.018; percent variation explained: ∼1.00%). Increasing levels of circulating FFA were associated with decreasing SI (P = 8.10 × 10-11). Increasing BMI, VAT, and SAT were also associated with decreasing SI (BMI: P = 4.98 × 10-71; VAT: P = 1.48 × 10-64; SAT: P = 4.21 × 10-62), but this relationship was not significantly mediated by FFA. VAT, but not BMI or SAT, interacts with levels of FFA to influence SI (P = 0.021). Conclusions: Although levels of circulating FFA are associated both with increasing adiposity and decreasing SI, they do not appear to mediate the association between levels of adiposity and SI in this large cohort of Hispanic-Americans. These results may indicate that FFA contribute to insulin resistance independent of adiposity.
AB - Context and Objective: We investigated whether free fatty acids (FFA) mediate the association between adiposity and insulin resistance in the Hispanic-American families of the Insulin Resistance Atherosclerosis Family Study. Design: In 815 Hispanic individuals in the Insulin Resistance Atherosclerosis Family Study, we tested for association between the following: 1) levels of adiposity [body mass index (BMI), visceral and sc adipose tissue area (VAT and SAT)] and circulating levels of FFA; 2) levels of circulating FFA and insulin sensitivity (SI); and 3) levels of adiposity and S I, additionally testing to see whether levels of FFA mediated or modified the relationship between adiposity and SI. Results: After adjusting for age, sex, clinic site, and admixture, increasing levels of BMI, VAT, and SAT were weakly associated with increasing levels of circulating FFA (BMI: P = 0.024; VAT: P =2.33 × 10-3; SAT: P = 0.018; percent variation explained: ∼1.00%). Increasing levels of circulating FFA were associated with decreasing SI (P = 8.10 × 10-11). Increasing BMI, VAT, and SAT were also associated with decreasing SI (BMI: P = 4.98 × 10-71; VAT: P = 1.48 × 10-64; SAT: P = 4.21 × 10-62), but this relationship was not significantly mediated by FFA. VAT, but not BMI or SAT, interacts with levels of FFA to influence SI (P = 0.021). Conclusions: Although levels of circulating FFA are associated both with increasing adiposity and decreasing SI, they do not appear to mediate the association between levels of adiposity and SI in this large cohort of Hispanic-Americans. These results may indicate that FFA contribute to insulin resistance independent of adiposity.
UR - http://www.scopus.com/inward/record.url?scp=84866145286&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84866145286&partnerID=8YFLogxK
U2 - 10.1210/jc.2012-1318
DO - 10.1210/jc.2012-1318
M3 - Article
C2 - 22761463
AN - SCOPUS:84866145286
SN - 0021-972X
VL - 97
SP - 3285
EP - 3291
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 9
ER -